Inc. MA Purchases New Position in Becton, Dickinson and Company (NYSE:BDX)

One analyst has rated the stock with a sell rating, five have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. Old Mutual Customised Solutions (Proprietary) Limited holds 0.19% of its portfolio in Becton Dickinson and Co (NYSE:BDX) for 6,264 shares. Becton, Dickinson and comprises 0.8% of Foster Dykema Cabot & Co. Inc. Boston Family Office LLC's holdings in Becton, Dickinson and were worth $2,057,000 as of its most recent SEC filing. Company trades at a P/E ratio of 39.04, and is more expensive than the average stock in the Medical Instruments & Supplies industry. Finally, Guardian Life Insurance Co. of America grew its holdings in shares of Becton, Dickinson and by 0.7% during the 1st quarter.

Pfenex Inc. (PFNX) stock moved with shift of -7.94% in the past week. Financial Architects Inc grew its holdings in shares of Becton, Dickinson and by 8.0% during the 2nd quarter. It also reduced its holding in Coca Cola Co (NYSE:KO) by 151,447 shares in the quarter, leaving it with 47,300 shares, and cut its stake in Newell Brands Inc (NYSE:NWL). Union Bankshares Corp now owns 22,335 shares of the medical instruments supplier's stock valued at $4,357,000 after acquiring an additional 381 shares during the last quarter. Finally, Boston Financial Mangement LLC increased its holdings in shares of Becton, Dickinson and by 10.2% in the 1st quarter. The Company caters to markets, such as healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

In related news, insider Ellen R. Strahlman sold 9,283 shares of the company's stock in a transaction dated Thursday, August 10th. The average 1-year price target for (BDX) reveals an average price target of $216.62 per share. Following the completion of the sale, the executive vice president now directly owns 29,323 shares in the company, valued at approximately $5,905,945.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

In other news, insider Thomas E. Polen, Jr. sold 5,971 shares of the business's stock in a transaction on Wednesday, August 9th. $190.77's average target is -1.16% below currents $193 stock price. The institutional investor held 88,340 shares of the health care company at the end of 2016Q4, valued at $14.63 million, up from 59,465 at the end of the previous reported quarter. The disclosure for this sale can be found here. Over the last three months, the shares of the company have changed -0.75% and performed 6.44% over the last six months. Insiders own 1.40% of the company's stock. Becton Dickinson had 31 analyst reports since August 7, 2015 according to SRatingsIntel. Piper Jaffray Companies reissued a "buy" rating and set a $213.00 target price on shares of Becton, Dickinson and in a report on Tuesday, September 12th. Becton Dickinson and Co (BDX) has risen 12.32% since September 19, 2016 and is uptrending. Stifel Nicolaus maintained Becton Dickinson and Co (NYSE:BDX) rating on Thursday, August 3. BidaskClub raised Becton, Dickinson and from a buy rating to a strong-buy rating in a research note on Tuesday, July 11th. Company's current RSI is 33.34.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another website, it was copied illegally and republished in violation of U.S. & worldwide trademark and copyright laws. The legal version of this news story can be accessed at

About 701,058 shares traded. Short interest, which represents the percentage of a stock's tradable shares now being shorted, captures what the market as a whole feels about a stock. During the last 52 weeks, the (NYSE:AA) price has been as high as $45.2 and as low as $20. The firm has a market cap of $43.88 billion, a price-to-earnings ratio of 55.84 and a beta of 1.06.

Becton, Dickinson and Company (NYSE:BDX) and Antares Pharma, Inc. They expect $2.37 EPS, up 11.79% or $0.25 from last year's $2.12 per share. The company had revenue of $3.04 billion for the quarter, compared to analysts' expectations of $3.06 billion. Jefferies maintained Becton Dickinson and Co (NYSE:BDX) rating on Tuesday, August 22. On a percent-of-sales basis, BDX's free cash flow was 0.2% while ATRS converted -0.01% of its revenues into cash flow. During the same quarter in the prior year, the firm earned $2.35 EPS.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Gm Advisory Grp invested in 0.07% or 1,226 shares. More interesting news about Adecoagro SA (NYSE:AGRO) was released by: and their article: "Adecoagro prices global 144A/REG S offering of its 6.000% Senior Notes ..." with publication date: September 15, 2017. This represents a $2.92 annualized dividend and a yield of 1.51%. The company has a payout ratio of 32.80%.

BD (BDX), a leading global medical technology company, and Euroclone reported a development and global distribution contract for molecular tests to detect emerging sexually-transmitted pathogens.

Like this


21 September 2017
'Big Brother' 19 Spoilers: Which Jury Members Will Vote For Paul, Josh?
With both of the Round 3 players planning to evict Christmas then we can most likely write her out of the F2 scenarios. Though Elena was tricked by Paul during the season, she truly realizes that it was awesome game play.

21 September 2017
Trump Says He Was 'Saddened' By 'Worst Ever' Emmy Ratings
Trump tweeted, "I was saddened to see how bad the ratings were on the Emmys last night - the worst ever". Colbert also bashed Trump's previous Emmy defeats as host of " Celebrity Apprentice ".

21 September 2017
Global Hepatitis Drugs Market Size 2017 : Bristol-Myers Squibb and GlaxoSmithKline
In Urological Cancer Drugs Market report analysis, traders and distributors analysis is given along with contact details. Next part of the Urological Cancer Drugs Market analysis report speaks about the manufacturing process.

21 September 2017
Counter terror police make third arrest in Parsons Green 'bucket bomb' probe
Friend Alison Griffiths said the couple had an 18-year-old and a 22-year-old staying with them recently. Mrs Jones had been struggling with one of the children in their care, he added.

21 September 2017
Yankees reduced to tears after kid struck by foul ball
Yankees manager Joe Girardi speaks Tuesday, Sept. 19, 2017 on the decision to start Luis Severino on Wednesday against the Twins. The federal Health Insurance Portability and Accountability Act, known as HIPAA, prevents the team from giving more information.

21 September 2017
Walt Disney Company (The) (DIS) Rating Reiterated by Wells Fargo & Company
It increased, as 67 investors sold DIS shares while 602 reduced holdings. 166 funds opened positions while 593 raised stakes. The stock has performed 0.55% over the last seven days, -2.25% over the last thirty, and -5.30% over the last three months.

21 September 2017
South Korea says Trump's North Korea rhetoric shows resolve
Trump called on member states to reject "business as usual" and not be "beholden to ways of the past which were not working". Now, in an interview with 21 News, Ohio Senator Sherrod Brown says the rhetoric used by Pres.

21 September 2017
Kremlin mouthpieces attack 'emotional' Morgan Freeman
Peskov described those leading the campaign as being in a state of "emotional exaltation, a continuation of a form of McCarthyism".

21 September 2017
Lopetegui urges Costa to sort club situation
Costa's club auto has already been moved from its parking place at the Chelsea's Cobham HQ to make room for new players. Lopetegui said: "Costa's summer has been unusual, strange, complicated - not just for him but for his club".

20 September 2017
This Weeks Target Prices For ProLogis, Inc. (NYSE:PLD)
Finally, BidaskClub upgraded shares of Prologis from a "buy" rating to a "strong-buy" rating in a report on Friday, August 18th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.63 by $0.00.